HOME >> MEDICINE >> NEWS
Highlights from the May 2007 Journal of the American Dietetic Association

CHICAGO -- The May 2007 issue of the Journal of the American Dietetic Association contains articles and research studies you may find of interest. Below is a summary of some of this months articles.

Snacking Can Benefit Older Adults

A nationally representative study of more than 2,000 people over age 65 found snacking is an "important dietary behavior" among older adults that can help ensure they consume enough calories in their diets, according to researchers at Auburn University and the U.S. Department of Agriculture.

Calorie consumption has been found to decrease as people get older by as much as 1,200 calories per day for men and 800 calories per day for women at age 70 compared to the consumption of 25-year-olds. Reasons for eating less include physical decline and illness, limited financial resources and social factors such as living alone. While some research has investigated meal patterns among older adults, less has been done on the role of snacks.

The researchers found 84 percent of the adults in the study ate snacks daily, with an average of about 2.5 snacks per day. Those who ate snacks consumed significantly higher amounts of calories, protein, carbohydrates and total fat than non-snackers. Snacks accounted for about one-quarter of all the snackers daily calories, about one-fifth of their fat intake and 14 percent of their protein.

"This study shows snacking is an important dietary behavior, both in terms of the prevalence and the (calorie) contribution, among older adults," the researchers write. "Whereas snacking may promote (calorie) imbalance resulting in obesity among other age groups, our results suggest snacking may ensure older adults consume diets adequate in (calories).

Poor Dietary Intake among Children with Sickle Cell Disease

As children with sickle cell disease age, their consumption of important nutrients declines and probably contributes to many of the childrens "
'"/>

Contact: Jennifer Starkey
media@eatright.org
312-899-4802
American Dietetic Association
1-May-2007


Page: 1 2 3

Related medicine news :

1. Highlights from the August 2007 Journal of the American Dietetic Association
2. Highlights from the June 2007 Journal of the American Dietetic Association
3. Highlights from the February 2007 Journal of the American Dietetic Association
4. Plastic surgery reflects on its past; Highlights innovations for the future of the specialty
5. Highlights from the July 2006 Journal of the American Dietetic Association
6. Drug-eluting stent controversy explored in the American Heart Hospital Journal
7. Journalists: Register now for CHEST 2007 in Chicago
8. SAGE to publish British Journal of Infection Control
9. Journal Sleep: Advanced cancer patients have less quality sleep
10. Journal Sleep: Longer CPAP use at night can normalize ones daytime functioning
11. Kavli Institutes Journalist Workshop, June 13, at Cornell

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Highlights from the May Journal the American Dietetic Association

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... some of the changes brought about by the disorder ... New research has found that people with diabetes who ... risk of having a severe low blood sugar (hypoglycemia) ... people with diabetes who aren,t depressed. "Depression ...
(Date:5/21/2013)... long been known for their health benefits, and ... like anti-cancer drugs are delivered to specific tumor ... how to create nanoparticles using natural lipids derived ... them as drug delivery vehicles. UofL scientists Huang-Ge ... team today (May 21, 2013), published their findings ...
(Date:5/21/2013)... Schaumburg, IL (PRWEB) May 21, 2013 ... administration for large, medium, and small organizations, will be ... featuring an experts team from Findley Davies. The presentation ... is up-to-date and in compliance with new Health Care ... ideas to engage employees. , “Benefit Express regularly ...
(Date:5/21/2013)... May 21, 2013 Dr. Francine Kaufman , ... she used with her patients in the 1980s: It weighed several ... For the most part, it could only be used in the ... years since then, and the advantages are greater as well. The ... outside of the body, often on a belt or a pocket. ...
(Date:5/21/2013)... 21, 2013 A plastic surgery ... for plastic surgery SEO services following an Internet ... to name the “Best Plastic Surgery SEO Services”. ... outcome was predictable. Well-known in the plastic surgery ... patients than any other selection based on superior ...
Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2Health News:Benefit Express to Host Workplace Wellness Webinar 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2
(Date:5/21/2013)... WESTBURY, N.Y. , May 21, 2013  Vasomedical, Inc. ... specializing in the design, manufacture and sale of medical devices ... today that Dr. Jun Ma , President ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES   ... study is to offer synopsis of the ...
(Date:5/21/2013)... Fla. , May 21, 2013  Janssen ... safety results from the global Phase 3 PROMISE ... inhibitor simeprevir (TMC435) led to sustained virologic response ... in 79 percent of treatment-experienced genotype 1 chronic ... including all stages of liver fibrosis, when administered ...
Breaking Medicine Technology:Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
Cached News: